Results 251 to 260 of about 79,528 (266)

The influence of metabolic syndrome components on plasma PAI-1 concentrations is modified by the PAI-1 4G/5G genotype and ethnicity

Atherosclerosis, 2008
Nigel J Crowther
exaly  

The activity of plasminogen activator inhibitor-1 (PAI-1) of human platelet

Fibrinolysis, 1990
N A Booth
exaly  

Increased PAI activity and PAI-1 antigen occurring with an oral fat load: associations with PAI-1 genotype and plasma active TGF-β levels

Atherosclerosis, 1998
Christopher D Byrne, Nicholas J Wareham, S E Humphries   +2 more
exaly  

PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy

Cancer Cell
Jia-Qi Chen, Yang-Si Li, Da-Yong Zheng   +2 more
exaly  

To pay or not to pay.

Modern healthcare, 2016
openaire   +1 more source

A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization

EMBO Journal, 2003
M Wilczynska, Malgorzata Wilczynska, Sergei Lobov   +2 more
exaly  

PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced Obesity

Frontiers in Pharmacology, 2018
Zheran Liu, Mao Luo, Ni Chen
exaly  

To pay or not to pay, that is the question?

BDJ In Practice, 2019
openaire   +1 more source

Regulation of cell adhesion by PAI‐1

Apmis, 1999
David J Loskutoff, G Deng
exaly  

Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity

Thrombosis Research, 2006
Remedios Castello, CARLOS Vazquez, Justo Aznar   +2 more
exaly